<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/92267032-BF6D-4396-8AB2-058B89D0964A"><gtr:id>92267032-BF6D-4396-8AB2-058B89D0964A</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Butter</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FI%2F00001423"><gtr:id>6EB21E97-0148-498E-9910-AF386F33D210</gtr:id><gtr:title>Targeting influenza vaccine antigens to antigen presenting cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/I/00001423</gtr:grantReference><gtr:abstractText>The generation of protective immune responses as early as possible in the life of the perinatal bird is a critical practical issue as pathogen challenge may occur at hatch. The targeting of vaccine antigens to dendritic cells (DC) may be used to provoke stronger and faster immune responses than are achieved with conventional vaccines. This project will seek to produce sterile immunity to avian viruses in hatchling chickens. Approaches reported in the mammalian literature include targeting specific DC cell surface molecules with either constructs of antigen-DC ligand or with specifically modified recombinant vaccine viruses. These approaches have not been reported in poultry, partly due to a lack of appropriate APC-specific reagents. The recent cloning of APC-specific molecules have now provided the tools both for targeting and the subsequent analysis of immune responses. We will initially target CD40, a costimulatory molecule cloned in John Young?s lab, and DEC 205 an endocytosis receptor cloned in this lab. This project will apply these strategies to the potentiation of vaccination against avian influenza virus (AIV). Targetting molecules will include both monoclonal antibodies and fusion proteins. These will be linked with relevant avian influenza virus antigens, and used to vaccinate chicks. Cellular and humoral immune responses will be measured and chicks challenged with low and high pathogenicity avian influenza virus.
Modification of vaccines viruses better to target DCs will be explored in collaboration with Adrian Hill?s group at Oxford. Recombinant adenovirus will be produced to include AIV genes and will utilise DC ligands to enhance the transduction of chicken DCs in vivo. It is anticipated that this project will provide data that will be used in further grant applications and approaches to industrial partners.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-07-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>805570</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our findings have been used in further study to understand the development of immune responses in avian species and also in the design of novel vaccines.</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>4B01F06A-1000-4EEE-A3AF-C32DFDFECA55</gtr:id><gtr:impactTypes/><gtr:outcomeId>5464a9a179a015.76889280</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have, for the first time, provided immunological tools to investigate antigen presenting cells within a bird. We have aslo designed a novel vaccine to protect chickens against avian influenza infection.</gtr:description><gtr:exploitationPathways>The development of further understanding and also of novel vaccines.</gtr:exploitationPathways><gtr:id>D2345603-C9ED-448C-BB36-BFF1E5139860</gtr:id><gtr:outcomeId>5464aa4420f726.03274437</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>35FCDC99-26ED-47A0-8B00-3C2285C6D1FF</gtr:id><gtr:title>Evolution of an expanded mannose receptor gene family.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358946d461e6c2872de7c750ec8896bd"><gtr:id>358946d461e6c2872de7c750ec8896bd</gtr:id><gtr:otherNames>Staines K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f94e94e32b30ae</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B50146EC-78DC-45F1-8873-4134029CDAC5</gtr:id><gtr:title>Expression of chicken DEC205 reflects the unique structure and function of the avian immune system.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358946d461e6c2872de7c750ec8896bd"><gtr:id>358946d461e6c2872de7c750ec8896bd</gtr:id><gtr:otherNames>Staines K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54635ce81c4039.03469904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BD31CB1-B27D-4D09-A22F-37900955B6F0</gtr:id><gtr:title>A Versatile Panel of Reference Gene Assays for the Measurement of Chicken mRNA by Quantitative PCR.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358946d461e6c2872de7c750ec8896bd"><gtr:id>358946d461e6c2872de7c750ec8896bd</gtr:id><gtr:otherNames>Staines K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>57f4e0acc12741.32238215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93ACB512-E394-4501-8F14-0D92F3F3F044</gtr:id><gtr:title>Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b8514ec0b79e0b031c1f237095a2e61"><gtr:id>1b8514ec0b79e0b031c1f237095a2e61</gtr:id><gtr:otherNames>Boyd AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>54635c6d8bbb32.37292203</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/I/00001423</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>